Mesenchymal stem/stromal cells as adjuvant therapy in COVID-19-associated acute lung injury and cytokine storm: Importance of cell identification

Theoretically, mesenchymal stem cells (MSCs) are very promising as adjuvant therapy to alleviate coronavirus disease 2019 (COVID-19)-associated acute lung injury and cytokine storm. Several published studies, which used MSCs to alleviate COVID-19-associated acute lung injury and cytokine storm, repo...

Descripción completa

Detalles Bibliográficos
Autor principal: Pawitan, Jeanne Adiwinata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968215/
https://www.ncbi.nlm.nih.gov/pubmed/35432737
http://dx.doi.org/10.4252/wjsc.v14.i3.264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8968215/
https://www.ncbi.nlm.nih.gov/pubmed/35432737
http://dx.doi.org/10.4252/wjsc.v14.i3.264

Ejemplares similares